Strict LDL Monitoring Helps Reduce Plaque Volume

colesterol ldl placasThe aim of this study was to explore the relationship between temporal changes in coronary plaque volume and the intensity of lipid lowering treatments using coronary computed tomography (CTA).

 

Coronary computed tomography has acceptable accuracy in terms of quantitative measurement on plaque volume, enough to identify changes in volume according to LDL levels.

 

This multicenter study included 467 patients undergoing multislice CT angiography over more than two years (mean 3.2 years), whose lab data were available within one month of both baseline and follow-up coronary CTA. Out of these patients, 147 were enrolled in the study, for they had visible plaque compromising 336 vessels.

 

Researchers compared patients reaching a cutoff value of 70 mg/dl LDL vs. those who did not. Patients below 70 mg/dl showed a significant reduction of plaque progression vs. those above 70 mg/dl (12.7 ± 38.2 mm3 vs. 44.2 ± 73.6 mm3, respectively; p=0.014).

 

In multivariable analyzis, the only factor influencing plaque progression was LDL cholesterol level.

 

Conclusion

Strict control of LDL levels significantly reduces plaque volume progression accordion to the non-invasive measurement with multislice CTA.

 

Original Title: Impact of Intensive LDL Cholesterol Lowering on Coronary Artery Atherosclerosis Progression A Serial CT Angiography Study.

Reference: Sanghoon Shin et al. J Am Coll Cardiol Img. 2016. Online First.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...